Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine
- 19 June 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (16) , 4319-4321
- https://doi.org/10.1016/j.bmcl.2004.05.079
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- DNA repair inhibition and cancer therapyJournal of Photochemistry and Photobiology B: Biology, 2001
- Cyclin‐dependent kinase inhibitors for treating cancerMedicinal Research Reviews, 2001
- Tyrosine kinase inhibitors: From rational design to clinical trialsMedicinal Research Reviews, 2001
- The DNA damage response: putting checkpoints in perspectiveNature, 2000
- Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene productsNature, 2000
- Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle RegulationJournal of Medicinal Chemistry, 2000
- Protein kinases as therapeutic targets.Pharmaceutical Research, 2000
- Interactions of TLC1 (Which Encodes the RNA Subunit of Telomerase), TEL1, and MEC1 in Regulating Telomere Length in the Yeast Saccharomyces cerevisiaeMolecular and Cellular Biology, 1999
- Circular chromosome formation in a fission yeast mutant defective in two ATM homologuesNature Genetics, 1998
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993